SCHEMBL30445057

SCHEMBL30445057

O=C1COc2cc(NC(=O)c3ccc(O)c(C(=O)Nc4cnccn4)c3)ccc2N1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 5/20 0.54
▸ CYP19A1 P11511 5/20 0.54
▸ CYP2C9 P11712 3/20 0.54
▸ CYP1A2 P05177 4/20 0.52
▸ CYP2C19 P33261 2/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ ALDH1A1 P00352 1/20 0.45
▸ POLB P06746 1/20 0.45
▸ MAPT P10636 1/20 0.45
▸ NSD2 O96028 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ ROCK2 O75116 3/20 0.41
▸ CYP11B1 P15538 1/20 0.40
▸ CYP11B2 P19099 1/20 0.40
▸ MALT1 Q9UDY8 1/20 0.40
▸ TRPV1 Q8NER1 2/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22284857 1.00 CYP3A4 (0.54) CYP3A4CYP19A1CYP2C9CYP1A2CYP2C19
SCHEMBL22284858 0.88 CYP3A4 (0.63) CYP3A4CYP19A1CYP2C9CYP1A2CYP2C19
SCHEMBL30444662 0.88 CYP3A4 (0.63) CYP3A4CYP19A1CYP2C9CYP1A2CYP2C19
SCHEMBL25547935 0.84 MAP4K1 (0.45) CYP19A1KMT2AMAPTROCK2CYP11B1
SCHEMBL18770343 0.81 CYP3A4 (0.80) CYP3A4CYP19A1CYP2C9CYP1A2CYP2C19
SCHEMBL18770354 0.79 RAB9A (0.59) CYP3A4CYP19A1CYP2C9CYP1A2CYP2C19
SCHEMBL30444594 0.79 RAB9A (0.59) CYP3A4CYP19A1CYP2C9CYP1A2CYP2C19
SCHEMBL14073935 0.78 MAPT (0.64) CYP3A4CYP19A1CYP2C9CYP1A2CYP2C19
SCHEMBL14073771 0.77 CYP3A4 (0.60) CYP3A4CYP19A1CYP2C9CYP1A2CYP2C19
SCHEMBL14073783 0.77 CYP3A4 (0.70) CYP3A4CYP19A1CYP2C9CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3365330-B1 PHARMACOPHORES, COMPOUNDS AND METHODS HAVING APPLICATION IN THE TREATMENT OF CANCER THROUGH INHIBITION OF CYP17A1 AND CYP19A1 MANGOSUTHU UNIV OF TECHNOLOGY (ZA) 2023-06-07 — — EP disclosed
Send feedback